Glaxosmithkline Consumer Healthcare

After the spectacular rise of Dolo 650’s sales offline and memes online, Crocin 650 released ads to get in on the action. But are ads a match for memes?

Chandigarh NCLT nod for HUL, GlaxoSmithKline Consumer Healthcare merger deal

On November 6, 2019, the Mumbai Bench of the NCLT had sanctioned the scheme and the order was subject to sanction of the Chandigarh Bench of NCLT.

Hold GlaxoSmithKline Consumer Healthcare target of Rs 7931: Sharekhan

Sharekhan recommended hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 7931 in its research report dated August 05, 2019.

Hold GlaxoSmithKline Consumer Healthcare; target of Rs 7972: Prabhudas Lilladher

Prabhudas Lilladher recommended hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 7972 in its research report dated August 05, 2019.

GSK Consumer Healthcare Q1 net profit up 24% to Rs 248 cr

The company had posted a net profit of Rs 200.44 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Consumer Healthcare said in a BSE filing.

Hold GlaxoSmithKline Consumer Healthcare; target of Rs 7931: Sharekhan

Sharekhan recommended Hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 7931 in its research report dated May 13, 2019.

GSK Consumer Healthcare Q4 profit up 35% to Rs 285 cr

Total income in the latest quarter was up 11.48 per cent to Rs 1,408.95 crore as against Rs 1,263.75 crore in the year-ago period.

GSK Consumer Healthcare falls 2% after Credit Suisse downgrades, cuts price target

The brokerage also slashed its price target by 7.4 percent to Rs 8,330 from Rs 9,000 apiece earlier as healthy volume growth and margin tailwinds may be behind.

GSKCH India gets CCI approval for merger deal with HUL

The Competition Commission of India (CCI) has approved the scheme of amalgamation between the two companies, through an-all equity deal, valuing the total business of the latter at Rs 31,700 crore.

GlaxoSmithKline Consumer Healthcare Q3 PAT seen up 17.1% YoY to Rs. 191.6 cr: Prabhudas Lilladher

Net Sales are expected to increase by 10.5 percent Y-o-Y (down 10.1 percent Q-o-Q) to Rs. 1,143.3 crore, according to Prabhudas Lilladher.

D-Street Buzz: Nifty Media underperforms, Zee falls 3%; Infosys sheds 2%, GSK Cons hits new 52-week high

Nifty Media was the underperforming sector, down 1.5 percent dragged by Zee Entertainment which shed 2 percent followed by DB Corp, Jagran Prakashan, UFO Moviez and PVR.

Crude oil prices sticking to current levels augurs well for market: Raamdeo Agrawal

Agarwal also said it's a good time to take a re-look at HUL after its deal with GSK Consumer Healthcare.

HUL approves merger with GSK Consumer, stocks gain 4%

HUL-GSK Consumer transaction is expected to be completed in one year subject to regulatory and shareholder approvals.

GSK Consumer Q2 net profit up 43% at Rs 275 crore

The company had posted a net profit of Rs 192.41 crore in the July-September quarter a year ago, GlaxoSmithKline Consumer Healthcare said in a filing to BSE.

GlaxoSmith Con standalone Jun-2018 sales at Rs 1,107.14 crore

GlaxoSmithKline Consumer Healthcare has reported a sales total income from operations of Rs 1,107.14 crore and a net profit of Rs 200.44 crore for the quarter ended Jun-2018

GSK Consumer Healthcare Q1 profit dips 17.6%

The company had posted a net profit of Rs 160.61 crore in the same period last fiscal, GSKCH said in a BSE filing.

Jubilant Food, Nestle, DFM Foods, GSK Consumer to get astro support: Satish Gupta

According to Satish Gupta of astrostocktips, food processing stocks like Jubilant Foodworks, Nestle India, DFM Food, Varun Beverages and GlaxoSmithKline Consumer Healthcare to get astrological support.

Buy GSK Consumer Healthcare, target Rs 6500: Deutsche Bank

The stock is trading at 26x FY2019 earnings and it has underperformed Sensex by 27 percent and 4 percent over last one and three years and Deutsche Consumer basket by 32 percent and 52 percent respectively,” the research firm said.

Buy Glaxosmithkline Consumer Healthcare; target of Rs 5950: Axis Direct

Axis Direct is bullish on Glaxosmithkline Consumer Healthcare has recommended buy rating on the stock with a target price of Rs 5950 in its research report dated May 18, 2017.

Hold Glaxosmithkline Consumer Healthcare; target of Rs 5657: Edelweiss

Edelweiss recommended hold rating on Glaxosmithkline Consumer Healthcare with a target price of Rs 5657 in its research report dated May 11, 2017.

Hindalco, ICICI Pru up 3-4%; FTSE Russell adds in largecap index

The index provider FTSE Russell will also add UPL, LIC Housing Finance and Piramal Enterprises to its large cap index. These changes will be effective from March 20, 2017.